These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
214 related articles for article (PubMed ID: 26405323)
1. Simulated Y-Site Compatibility of Vancomycin and Piperacillin-Tazobactam. Wade J; Cooper M; Ragan R Hosp Pharm; 2015 May; 50(5):376-9. PubMed ID: 26405323 [TBL] [Abstract][Full Text] [Related]
2. Compatibility of Ceftazidime-Avibactam, Ceftolozane-Tazobactam, and Piperacillin-Tazobactam with Vancomycin in Dextrose 5% in Water. Meyer K; Santarossa M; Danziger LH; Wenzler E Hosp Pharm; 2017 Mar; 52(3):221-228. PubMed ID: 28439137 [No Abstract] [Full Text] [Related]
3. Y-site Incompatibility Between Premix Concentrations of Vancomycin and Piperacillin-Tazobactam: Do Current Compatibility Testing Methodologies Tell the Whole Story? Kufel WD; Miller CD; Johnson PR; Reid K; Zahra JJ; Seabury RW Hosp Pharm; 2017 Feb; 52(2):132-137. PubMed ID: 28321140 [No Abstract] [Full Text] [Related]
4. Compatibility of piperacillin sodium plus tazobactam with selected drugs during simulated Y-site injection. Trissel LA; Martinez JF Am J Hosp Pharm; 1994 Mar; 51(5):672-8. PubMed ID: 8203388 [TBL] [Abstract][Full Text] [Related]
5. Visual and absorbance analyses of admixtures containing vancomycin and piperacillin-tazobactam at commonly used concentrations. O'Donnell JN; Venkatesan N; Manek M; Rhodes NJ; Scheetz MH Am J Health Syst Pharm; 2016 Feb; 73(4):241-6. PubMed ID: 26843502 [TBL] [Abstract][Full Text] [Related]
6. Y-site compatibility of vancomycin and piperacillin/tazobactam at commonly utilized pediatric concentrations. Nichols KR; Demarco MW; Vertin MD; Knoderer CA Hosp Pharm; 2013 Jan; 48(1):44-7. PubMed ID: 24421422 [TBL] [Abstract][Full Text] [Related]
7. Physical compatibility of ceftolozane-tazobactam with selected i.v. drugs during simulated Y-site administration. Thabit AK; Hamada Y; Nicolau DP Am J Health Syst Pharm; 2017 Jan; 74(1):e47-e54. PubMed ID: 28007721 [TBL] [Abstract][Full Text] [Related]
8. Physical compatibility of vancomycin and piperacillin sodium-tazobactam at concentrations typically used during prolonged infusions. Leung E; Venkatesan N; Ly SC; Scheetz MH Am J Health Syst Pharm; 2013 Jul; 70(13):1163-6. PubMed ID: 23784164 [TBL] [Abstract][Full Text] [Related]
9. Physical compatibility of telavancin hydrochloride with select i.v. drugs during simulated Y-site administration. Housman ST; Tessier PR; Nicolau DP; Kuti JL Am J Health Syst Pharm; 2011 Dec; 68(23):2265-70. PubMed ID: 22095816 [TBL] [Abstract][Full Text] [Related]
10. Physical compatibility of isavuconazonium sulfate with select i.v. drugs during simulated Y-site administration. So W; Kim L; Thabit AK; Nicolau DP; Kuti JL Am J Health Syst Pharm; 2017 Jan; 74(1):e55-e63. PubMed ID: 28007722 [TBL] [Abstract][Full Text] [Related]
11. Compatibility of Vancomycin and Oxacillin During Simulated Y-Site Delivery. Teibel HM; Knoderer CA; Nichols KR Hosp Pharm; 2015 Sep; 50(8):710-3. PubMed ID: 26823620 [TBL] [Abstract][Full Text] [Related]
12. Compatibility of allopurinol sodium with selected drugs during simulated Y-site administration. Trissel LA; Martinez JF Am J Hosp Pharm; 1994 Jul; 51(14):1792-9. PubMed ID: 7942908 [TBL] [Abstract][Full Text] [Related]
13. Y-Site Compatibility of Intravenous Levetiracetam With Commonly Used Critical Care Medications. Lee TM; Villareal CL; Meyer LM Hosp Pharm; 2021 Aug; 56(4):282-286. PubMed ID: 34381262 [No Abstract] [Full Text] [Related]
14. Stability of piperacillin sodium-tazobactam sodium and ranitidine hydrochloride in 0.9% sodium chloride injection during simulated Y-site administration. Choi JS; Burm JP; Jhee SS; Chin A; Ulrich RW; Gill MA Am J Hosp Pharm; 1994 Sep; 51(18):2273-6. PubMed ID: 7801988 [TBL] [Abstract][Full Text] [Related]
15. Physical Compatibility of Cefiderocol with Selected Intravenous Drugs During Simulated Y-site Administration. Lu J; Liu Q; Kupiec TC; Vail H; Lynch LR; Fam DS; Vu NT Int J Pharm Compd; 2021; 25(1):52-61. PubMed ID: 33503010 [TBL] [Abstract][Full Text] [Related]
16. Compatibility of ceftobiprole medocaril with selected drugs during simulated Y-site administration. Chan P; Bishop A; Kupiec TC; Trissel LA; Gole D; Jimidar IM; Vermeersch H Am J Health Syst Pharm; 2008 Aug; 65(16):1545-51. PubMed ID: 18693210 [TBL] [Abstract][Full Text] [Related]
17. Compatibility of doripenem with other drugs during simulated Y-site administration. Brammer MK; Chan P; Heatherly K; Trusley C; Kupiec TC; Trissel LA; Psathas PA; Gilmor T; Schaufelberger D Am J Health Syst Pharm; 2008 Jul; 65(13):1261-5. PubMed ID: 18574017 [TBL] [Abstract][Full Text] [Related]
18. Compatibility of gemcitabine hydrochloride with 107 selected drugs during simulated Y-site injection. Trissel LA; Martinez JF; Gilbert DL J Am Pharm Assoc (Wash); 1999; 39(4):514-8. PubMed ID: 10467816 [TBL] [Abstract][Full Text] [Related]
19. Visual, turbidimetric, and particle-content assessment of compatibility of vinorelbine tartrate with selected drugs during simulated Y-site injection. Trissel LA; Martinez JF Am J Hosp Pharm; 1994 Feb; 51(4):495-9. PubMed ID: 8017415 [TBL] [Abstract][Full Text] [Related]
20. Visual compatibility of colistin injection with other antibiotics during simulated Y-site administration. Katip W Am J Health Syst Pharm; 2017 Jul; 74(14):1099-1102. PubMed ID: 28687555 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]